Heranba Industries Limited

32%

of FY22) 60+ Revenue from Institutional customers** (as of FY22) 9400+ Dealers across India 32% Revenue from Exports as % of sales (as of H1FY23) ~25% Revenue from Top 10 customers (as of F

25%

s of FY22) 9400+ Dealers across India 32% Revenue from Exports as % of sales (as of H1FY23) ~25% Revenue from Top 10 customers (as of FY22) 29.0% ROE# (as of H1FY23) **Institutional Customers

29.0%

ue from Exports as % of sales (as of H1FY23) ~25% Revenue from Top 10 customers (as of FY22) 29.0% ROE# (as of H1FY23) **Institutional Customers includes Technical Exports, Technical Domestic, Bra

₹1000 Crore

d into Branded Formulations through its own distribution network TURNOVER Achieved Turnover of ₹1000 Crores INITIAL PUBLIC OFFERING Listed on BSE & NSE Commissioned Unit No. 4 in Vapi Value Chain Val

rs,

ING Listed on BSE & NSE Commissioned Unit No. 4 in Vapi Value Chain Value Chain HIL over the years, has scaled up the manufacturing of Intermediates, Technicals and Formulations which form part o

₹10,655 million

anaging Director of Heranba Industries Limited, commented, “The Company’s 9M FY23 revenues stood at ₹10,655 million impacted by challenging global macros including prolonged geopolitical concerns, rising inflation i

7 %

4,500 4,000 3,500 3,000 2,500 2,000 1,500 1,000 500 - % 6 0 9 1 . . 9 4 3 6 7 % 9 4 6 1 . . 1 5 4 0 7 % 1 4 9 . . 8 4 4 6 2 % 3 5 3 1 . . 6 8 4 3 5 % 6 2 1 1 . . 1

2 %

0 1,000 500 - % 6 0 9 1 . . 9 4 3 6 7 % 9 4 6 1 . . 1 5 4 0 7 % 1 4 9 . . 8 4 4 6 2 % 3 5 3 1 . . 6 8 4 3 5 % 6 2 1 1 . . 1 8 6 7 4 % 4 1 5 . . 0 9 3 4 1 11% 19% 43% 4%

5 %

1 . . 9 4 3 6 7 % 9 4 6 1 . . 1 5 4 0 7 % 1 4 9 . . 8 4 4 6 2 % 3 5 3 1 . . 6 8 4 3 5 % 6 2 1 1 . . 1 8 6 7 4 % 4 1 5 . . 0 9 3 4 1 11% 19% 43% 4% 38% 30% 27% 29% 20% 31%

4 %

1 . . 1 5 4 0 7 % 1 4 9 . . 8 4 4 6 2 % 3 5 3 1 . . 6 8 4 3 5 % 6 2 1 1 . . 1 8 6 7 4 % 4 1 5 . . 0 9 3 4 1 11% 19% 43% 4% 38% 30% 27% 29% 20% 31% 31% 18% . 1 3 3 3 2 4

11%

. . 8 4 4 6 2 % 3 5 3 1 . . 6 8 4 3 5 % 6 2 1 1 . . 1 8 6 7 4 % 4 1 5 . . 0 9 3 4 1 11% 19% 43% 4% 38% 30% 27% 29% 20% 31% 31% 18% . 1 3 3 3 2 4 , . 4 1 2 0 8 2 , . 4 9

19%

8 4 4 6 2 % 3 5 3 1 . . 6 8 4 3 5 % 6 2 1 1 . . 1 8 6 7 4 % 4 1 5 . . 0 9 3 4 1 11% 19% 43% 4% 38% 30% 27% 29% 20% 31% 31% 18% . 1 3 3 3 2 4 , . 4 1 2 0 8 2 , . 4 9 3 5

Financial Assets

2

Tel

1

Email

1

Investor Relations Contacts

1

Financial Assets

(i) Investments (ii) Loans (iii) Other Financial Assets Current tax assets (Net) Other non-current assets Total Non-Current Assets (I) Current Assets Inventories

Financial Assets

(i) Trade Receivables (ii) Cash and cash equivalents (iii) Loans (iv) Other financial assets Other current assets Total Current Assets (II) Total Assets (I + II) FY19 FY20 FY21 FY22 H1FY23 (₹ IN MILLION) 511.39 159.70 954.41 377.72 1,334.35 96.95 1,934.26 142.29 1940.22 350.93 0.24 .71 1.48 37.31 100.98 21.27 84.27 241.71 10.20 97.01 113.62 28.06 72.47 344.58 80.66 1,088.39 1,534.37 1,881.20 2,311.97 1,138.94 1,455.18 1,659.86 2,557.39 3435.35 2,532.72 209.65 0 15.4 619.33 4,516.04 5,604.43 2,584.67 31.94 8.95 17.17 615.35 4,713.26 6,247.63 3,417.62 847.80 4,468.80 1198.71 19.97 606.68 6,551.93 8,433.13 19.55 514.73 8,759.19 10,647.90 11,071.16 13,245.32 6.75 5.83 52.02 46.3 195.38 2597.42 5456.71 1224.45 20.12 511.27 Standalone Balance Sheet (2/2) PARTICULARS Equity and liabilities Equity Equity share capital Other equity Total Equity Liabilities Non-Current Liabilities Financial Liabilities (i) Borrowings (ii) Other Financial Liabilities Provisions Other Non-current liabilities Defer